Post-acute Rehabilitation

 

Interview: Konstantin Mehl, Founder & CEO, Kaia Health

We talk to Konstantin Mehl, the founder of Kaia, a digital therapy app for chronic lower back pain which recently closed its Series A and is seeing 25% monthly organic growth in paying B2C users, he claims.

Does Value Health have a future?

Value health is the revolutionary idea pioneered by Harvard guru Michael Porter. He had the temerity to suggest providers should be rewarded for quality, rather than activity and that the patient should be viewed and consulted as customers. Invented in the early noughties, it hit a high water mark 7-8 years ago when Obamacare was rolled out incorporating the concept. Then it felt like an inexorable river.

TVM in JV with Ukrainian rehabilitation group

Dubai-based TVM Capital Healthcare has invested in a joint venture with a Ukrainian group whose founder pioneered a method of cerebral palsy rehabilitation. It is not the first Middle Eastern player to splash on East European rehab expertise.

FREE BLOG Things we learned at HBI 2019

This week delegates from around the world descended on London for HBI 2019 to discuss the healthcare market and its various sub-sectors. Here are the things we learnt:

Median process gets put back “3-4 years”

The sale of German rehabilitation giant Median Kliniken by owners Waterland may have been put back, HBI hears, though sources close to the company suggest otherwise.

French hospital tariffs to increase in 2019, and reward quality

France's health minister has announced that tariffs to acute hospitals will rise in 2019 for the first time in eight years, and reward quality for the first time ever, while rehab and psychiatry for-profits will be "stable". We talk to LEK's Paris-based co-head of European Healthcare Practice about the news and the for-profit hospital sector's prospects in France generally.

“Surgery prevention” group seeks Indian and US expansion

We talk to the CEO of QI Spine Clinic, a network of back and neck therapy clinics in India which has also developed a data-driven platform for diagnosis and treatment that it is looking to franchise out to partner practitioners in India, the US and potentially globally. The group is planning a Series B to the tune of $10-20m to fund growth.

Find Us